The effect of placebo adherence on reducing cardiovascular mortality: A meta-analysis

Clinical Research in Cardiology

Volumn 103, Issue 3, 2014, Pages 229-235

  Zhao, Yue ^a   Cheng, Cai ^b   Yang, Ai Fang ^a   Tang, Feng Min ^a   Chen, Li ^a   Wang, Bin ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cardiovascular mortality; Meta analysis; Placebo adherence

Indexed keywords

PLACEBO;

ARTICLE; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; FOLLOW UP; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; MEDICATION COMPLIANCE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; HUMANS; MEDICATION ADHERENCE; ODDS RATIO; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84897873247     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0642-6     Document Type: Article

References (37)

1. Osterberg L, Blaschke T (2005) Drug therapy - adherence to medication. N Engl J Med 353:487-497
2. Ho PM, Maddox TM, Shetterly SM, Rumsfeld JS, Magid DJ (2008) The costs of healthcare associated with medication nonadherence. Circulation 117:E460
3. Ewen S, Rettig-Ewen V, Mahfoud F, Bohm M, Laufs U (2013) Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol. doi:10.1007/s00392-013-0616-8
4. Herrler T, Bohm M, Heeschen C (2008) More good reasons for adherence to statin therapy during acute coronary syndromes. Eur Heart J 29:2061-2063
5. Rublee DA, Chen SY, Mardekian J, Wu N, Rao P, Boulanger L (2012) Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Am J Ther 19:24-32
6. Rasmussen JN, Chong A, Alter DA (2007) Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297:177-186 (Pubitemid 46089734)
7. Padula AM, Pressman AR, Vittinghoff E, Grady D, Neuhaus J, Ackerson L, Rudd P, Avins AL (2012) Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med 125:804-810
8. Pressman A, Avins AL, Neuhaus J, Ackerson L, Rudd P (2012) Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemp Clin Trials 33:492-498
9. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA (2006) A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333:15
10. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366:2005-2011 (Pubitemid 41773375)
11. Irvine J, Baker B, Smith J, Jandciu S, Paquette M, Cairns J, Connolly S, Roberts R, Gent M, Dorian P (1999) Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med 61:566-575 (Pubitemid 29360322)
12. Shepherd JCSLR (1997) Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study. Eur Heart J 18:1718-1724
13. Obias-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, Wimbush F, Somelofski C, Goldner F (1996) Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST). Ann Epidemiol 6:93-101 (Pubitemid 26097393)
14. Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH (1994) Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study. Arch Intern Med 154:2649-2657
15. Gallagher EJ, Viscoli CM, Horwitz RI (1993) The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 270:742-744 (Pubitemid 23226634)
16. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J (1990) Treatment adherence and risk of death after a myocardial infarction. Lancet 336:542-545 (Pubitemid 20278106)
17. Pl C (1980) Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 303:1038-1041
18. Fernandes JL, Serrano CV, Toledo F, Hunziker MF, Zamperini A, Teo FH, Oliveira RT, Blotta MH, Rondon MU, Negrao CE (2011) Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease. Clin Res Cardiol 100:77-84
19. Walenta K, Sinning JM, Werner C, Bohm M (2011) Hotline update of clinical trials and registries presented at the at the European Society of Cardiology Congress in Paris 2011. Clin Res Cardiol 100:955-971
20. Andersohn F, Willich SN (2009) The healthy adherer effect. Arch Intern Med 169:1635-1636
21. Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers J, Horne R (2008) Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 64:47-54 (Pubitemid 350297308)
22. Blaschke TF, Osterberg L, Vrijens B, Urquhart J (2012) Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 52:275-301
23. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A (1983) Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 53:96-104 (Pubitemid 13031772)
24. Millar-Craig MW, Bishop CN, Raftery EB (1978) Circadian variation of blood-pressure. Lancet 1:795-797
25. Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Stork S (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263-272
26. Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J (2004) Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med 27:117-124 (Pubitemid 38364891)
27. Jespersen L, Abildstrom SZ, Hvelplund A, Prescott E (2013) Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol 102:571-581
28. Schowalter M, Gelbrich G, Stork S, Langguth JP, Morbach C, Ertl G, Faller H, Angermann CE (2013) Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol 102:269-278
29. Kripalani S, Henderson LE, Jacobson TA, Vaccarino V (2008) Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc 83:529-535 (Pubitemid 351716999)
30. Ayalon L (2008) Subjective cognitive functioning as a predictor of all cause mortality in an Israeli national sample of community dwelling older adults. Int J Geriatr Psychiatry 23:830-836
31. Rudman LA, Gonzales MH, Borgida E (1999) Mishandling the gift of life: noncompliance in renal transplant patients. J Appl Soc Psychol 29:834-851
32. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J (1998) Persistence of use of lipid-lowering medications - A cross-national study. JAMA J Am Med Assoc 279:1458-1462 (Pubitemid 28228203)
33. White HD (2005) Adherence and outcomes: it's more than taking the pills. Lancet 366:1989-1991
34. Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119:3028-3035
35. Laufs U, Rettig-Ewen V, Bohm M (2011) Strategies to improve drug adherence. Eur Heart J 32:264-268
36. Gitt AK, Junger C, Jannowitz C, Karmann B, Senges J, Bestehorn K (2011) Adherence of hospital-based cardiologists to lipid guidelines in patients at high risk for cardiovascular events (2L registry). Clin Res Cardiol 100:277-287
37. Bohm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S (2013) Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J 166(306-314):e7